Cleveland researchers test novel gene therapy for glioblastoma

20:00 EDT 2 Jun 2019 | AAAS

(University Hospitals Cleveland Medical Center) A novel gene therapy clinical trial for glioblastoma multiforme (GBM) shows promising results. The trial focuses on turning patients with a poor prognosis into those with a good prognosis. In the trial's Phase 1, median survival of GBM patients was 3.5-fold the expected survival based on published modeling studies with actual data from patients with similar situations in randomized clinical trials.

Original Article: Cleveland researchers test novel gene therapy for glioblastoma


More From BioPortfolio on "Cleveland researchers test novel gene therapy for glioblastoma"

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...